Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Learn more about this revolutionary cancer treatment.
Understand the Basics
Find clinical trials that match your diagnosis, stage and treatment history.
Search Online
Meet the CRI scientists committed to the development of immunotherapy.
Read More
Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.
By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer.
See how immunotherapy works
See Where Your Money Goes
Fundraise for immunotherapy
Share Stories and Connect
Become a corporate sponsor
Cancer Research Institute | National Headquarters 29 Broadway, 4th Floor | New York, NY 10006-3201
(800) 992-2623(212) 832-9376Staff Directory
Previously treated patients with these cancer types can now receive anti-PD-1 immunotherapy; nivolumab for HCC and pembrolizumab for advanced stomach or gastroesophageal cancer.
The final day of CICON17 explored two newer immunotherapy approaches that reflect broader understanding of tumor-immune interactions the field has come to appreciate.